Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Bradley C . Leibovich, M.D.

Back to Research Profile

  1. Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 2009 Dec; 182(6):2601-6. Epub 2009 Oct 17.
    View PubMed
  2. Tollefson MK, Krambeck AE, Leibovich BC, Blute ML, Chow GK. Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient. Urology 2009 Oct 06. [Epub ahead of print]
    View PubMed
  3. Baden J, Green G, Painter J, Curtin K, Markiewicz J, Jones J, Astacio T, Canning S, Quijano J, Guinto W, Leibovich BC, Nelson JB, Vargo J, Wang Y, Wuxiong C. Multicenter evaluation of an investigational prostate cancer methylation assay. J Urol 2009 Sep; 182(3):1186-93. Epub 2009 Jul 21.
    View PubMed
  4. Siddiqui SA, Frank I, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol. BJU Int 2009 Sep; 104(6):778-85. Epub 2009 Mar 11.
    View PubMed
  5. Baden J, Green G, Painter J, Curtin K, Markiewicz J, Jones J, Astacio T, Canning S, Quijano J, Guinto W, Leibovich BC, Nelson JB, Vargo J, Wang Y, Wuxiong C. Multicenter evaluation of an investigational prostate cancer methylation assay. J Urol 2009 Sep; 812(3):1186-93.
    View PubMed
  6. Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC. Locally recurrent prostate cancer after initial radiation therapy: comparison of salvage radical prostatectomy versus cryotherapy. J Urol 2009 Aug; 182(2):517-27.
    View PubMed
  7. Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol 2009 Aug; 182(2):517-25.
    View PubMed
  8. Kayalar N, Leibovich BC, Orszulak TA, Schaff HV, Sundt TM, Daly RC, G A McGregor C. Concomitant surgery for renal neoplasm with pulmonary tumor embolism. J Thorac Cardiovasc Surg 2009 Jun 09. [Epub ahead of print]
    View PubMed
  9. Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Leibovich BC, Kwon ED. T-cell Co-regulatory Molecule Expression in Renal Angiomyolipoma and Pulmonary Lymphangioleiomyomatosis. Urology 2009 Jun 05. [Epub ahead of print]
    View PubMed
  10. Parker AS, Leibovich BC, Lohse CM, Sheinin Y, Kuntz SM, Eckel-Passow JE, Blute ML, Kwon ED. Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. Cancer 2009 May 15; 115(10):2092-103.
    View PubMed
  11. Gettman MT, Pereira CW, Lipsky K, Wilson T, Arnold JJ, Leibovich BC, Karnes RJ, Dong Y. Use of high fidelity operating room simulation to assess and teach communication, teamwork and laparoscopic skills: initial experience. J Urol 2009 Mar; 181(3):1289-96. Epub 2009 Jan 18.
    View PubMed
  12. Bruner B, Ashley R, Leibovich B, Blute M, LeRoy A. Case report: percutaneous catheter management of persistent urine leak due to iatrogenic infundibular stenosis after partial nephrectomy. J Endourol 2009 Jan; 23(1):37-41.
    View PubMed
  13. Leibovich BC, Blute ML. Lymph node dissection in the management of renal cell carcinoma. Urol Clin North Am 2008 Nov; 35(4):673-8; viii.
    View PubMed
  14. Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC. Outcomes following partial nephrectomy by tumor size. J Urol 2008 Nov; 180(5):1912-7. Epub 2008 Sep 17.
    View PubMed
  15. Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC. Outcomes following partial nephrectomy by tumor size. J Urol 2008 Nov; 180(5):1912-7. Epub 2008 Sep 17.
    View PubMed
  16. Inman BA, Davies JD, Rangel LJ, Bergstralh EJ, Kwon ED, Blute ML, Karnes RJ, Leibovich BC. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. Cancer 2008 Oct 1; 113(7):1544-51.
    View PubMed
  17. Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Kwon ED, Leibovich BC. Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Urology 2008 Oct; 72(4):927-32. Epub 2008 Mar 28.
    View PubMed
  18. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol 2008 Oct; 54(4):855-63. Epub 2008 May 09.
    View PubMed
  19. Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Urol 2008 Oct; 180(4 Part 1):1302.
    View PubMed
  20. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 2008 Aug 15; 14(16):5150-7. Epub 2008 Aug 11.
    View PubMed
  21. Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer 2008 Aug 1; 113(3):450-60.
    View PubMed
  22. Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clin Cancer Res 2008 Aug 1; 14(15):4800-8.
    View PubMed
  23. Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Cheville JC, Blute ML, Russo P, Kwon ED, Allison JP. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res 2008 Aug 1; 68(15):6054-8.
    View PubMed
  24. Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Cheville JC, Blute ML, Russo P, Kwon ED, Allison JP. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res 2008 Aug 1; 68(15):6054-8.
    View PubMed
  25. Parker AS, Lohse CM, Leibovich BC, Cheville JC, Sheinin YM, Kwon ED. Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma. Hum Pathol 2008 Aug; 39(8):1176-84. Epub 2008 Jun 05.
    View PubMed
  26. Routh JC, Bacon DR, Leibovich BC, Zincke H, Blute ML, Frank I. How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery. BJU Int 2008 Aug; 102(3):301-4. Epub 2008 Apr 11.
    View PubMed
  27. Gettman MT, Karnes RJ, Arnold JJ, Klipfel JM, Vierstraete HT, Johnson ME, Johnson DR, Leibovich BC. Urology resident training with an unexpected patient death scenario: experiential learning with high fidelity simulation. J Urol 2008 Jul; 180(1):283-8; discussion 288. Epub 2008 May 21.
    View PubMed
  28. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol 2008 Jul; 180(1):99-103; discussion 103. Epub 2008 May 15.
    View PubMed
  29. Crispen PL, Leibovich BC. What is the clinical significance of ipsilateral renal lesions during nephron-sparing surgery? Nature Clinical Practice Urology 2008 Jul; 5(7):360-1.
    View PubMed
  30. Granberg CF, Boorjian SA, Schaff HV, Orszulak TA, Leibovich BC, Lohse CM, Cheville JC, Blute ML. Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass. Urology 2008 Jul; 72(1):148-52. Epub 2008 Apr 18.
    View PubMed
  31. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol 2008 Jul; 180(1):99-103; discussion 103. Epub 2008 May 15.
    View PubMed
  32. Gettman MT, Karnes RJ, Arnold JJ, Klipfel JM, Vierstraete HT, Johnson ME, Johnson DR, Leibovich BC. Urology resident training with an unexpected patient death scenario: experiential learning with high fidelity simulation. J Urol 2008 Jul; 180(1):283-8; discussion 288. Epub 2008 May 21.
    View PubMed
  33. Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int 2008 Jun; 101(11):1375-9.
    View PubMed
  34. Atwell TD, Farrell MA, Leibovich BC, Callstrom MR, Chow GK, Blute ML, Charboneau JW. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol 2008 Jun; 179(6):2136-40; discussion 2140-1.
    View PubMed
  35. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 2008 Jun; 179(6):2146-51; discussion 2151. Epub 2008 Apr 18.
    View PubMed
  36. Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 2008 Jun; 179(6):2158-63.
    View PubMed
  37. Atwell TD, Farrell MA, Leibovich BC, Callstrom MR, Chow GK, Blute ML, Charboneau JW. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol 2008 Jun; 179(6):2136-40; discussion 2140-1.
    View PubMed
  38. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 2008 Jun; 179(6):2146-51; discussion 2151. Epub 2008 Apr 18.
    View PubMed
  39. Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 2008 Jun; 179(6):2158-63.
    View PubMed
  40. Vener T, Derecho C, Baden J, Wang H, Rajpurohit Y, Skelton J, Mehrotra J, Varde S, Chowdary D, Stallings W, Leibovich B, Robin H, Pelzer A, Schafer G, Auprich M, Mannweiler S, Amersdorfer P, Mazumder A. Development of a multiplexed urine assay for prostate cancer diagnosis. Clin Chem 2008 May; 54(5):874-82. Epub 2008 Mar 13.
    View PubMed
  41. Takahashi N, Kawashima A, Glockner JF, Hartman RP, Leibovich BC, Brau AC, Beatty PJ, King BF. Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology 2008 May; 247(2):451-7. Epub 2008 Mar 27.
    View PubMed
  42. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 2008 May; 179(5 Suppl):S7-S11.
    View PubMed
  43. Takahashi N, Kawashima A, Glockner JF, Hartman RP, Leibovich BC, Brau AC, Beatty PJ, King BF. Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology 2008 May; 247(2):451-7. Epub 2008-03-27.
    View PubMed
  44. Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 2008 Apr 1; 112(7):1471-9.
    View PubMed
  45. Parker A, Lohse C, Cheville J, Leibovich B, Igel T, Blute M. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Int J Urol 2008 Apr; 15(4):304-8.
    View PubMed
  46. Thompson RH, Leibovich BC, Karnes RJ, Bergstralh EJ, Blute ML. Radical retropubic prostatectomy in immunosuppressed transplant recipients. J Urol 2008 Apr; 179(4):1349-52; discussion 1352-3. Epub 2008 Mar 04.
    View PubMed
  47. Thompson RH, Leibovich BC, Karnes RJ, Bergstralh EJ, Blute ML. Radical retropubic prostatectomy in immunosuppressed transplant recipients. J Urol 2008 Apr; 179(4):1349-52; discussion 1352-3 Epub 2008 Mar 4.
    View PubMed
  48. Inman BA, Frigola X, Harris KJ, Kuntz SM, Lohse CM, Leibovich BC, Kwon ED. Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. J Immunol 2008 Mar 1; 180(5):3578-84.
    View PubMed
  49. Magera JS Jr, Frank I, Lohse CM, Leibovich BC, Cheville JC, Blute ML. Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J Urol 2008 Mar; 179(3):853-6. Epub 2008 Jan 25.
    View PubMed
  50. Magera JS, Frank I, Lohse CM, Leibovich BC, Cheville JC, Blute ML. Analysis of repeat nephron sparing surgery as treatment option in patients with solid mass in renal remnant. J Urol 2008 Mar; 179(3):853-6.
    View PubMed
  51. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008 Feb; 179(2):468-71; discussion 472-3.
    View PubMed
  52. Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol 2008 Feb; 179(2):474-7.
    View PubMed
  53. Magera JS Jr, Leibovich BC, Lohse CM, Sengupta S, Cheville JC, Kwon ED, Blute ML. Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. Urology 2008 Feb; 71(2):278-82.
    View PubMed
  54. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008 Feb; 179(2):468-71; discussion 472-3.
    View PubMed
  55. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008 Feb; 179(2):468-73.
    View PubMed
  56. Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol 2008 Feb; 179(2):474-7.
    View PubMed
  57. Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. BJU Int 2008 Jan; 101(2):170-4.
    View PubMed
  58. Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, Blute ML. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology 2007 Dec; 70(6):1064-8.
    View PubMed
  59. Webster WS, Thompson RH, Cheville JC, Lohse CM, Blute ML, Leibovich BC. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology 2007 Nov; 70(5):900-4.
    View PubMed
  60. Granberg CF, Krambeck AE, Leibovich BC, Frank I, Lohse CM, Gettman MT, Blute ML, Chow GC. Potential underdetection of pT(3a) renal-cell carcinoma with laparoscopic morcellation. J Endourol 2007 Oct; 21(10):1183-6.
    View PubMed
  61. Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer 2007 Aug 15; 110(4):783-90.
    View PubMed
  62. Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED. KI-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer 2007 Aug 15; 110(4):783-90.
    View PubMed
  63. Leibovich BC. Predicting RCC outcomes: an update. Renal & Urology News Aug Aug 2007; 6(8):20-2.
    View PubMed
  64. Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol 2007 Aug; 178(2):440-5; discussion 444. Epub 2007 Jun 11.
    View PubMed
  65. Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol 2007 Aug; 178(2):440-5; discussion 444. Epub 2007-06-11.
    View PubMed
  66. Thompson RH, Blute ML, Slezak JM, Bergstralh EJ, Leibovich BC. Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? J Urol 2007 Aug; 178(2):459-63; discussion 463. Epub 2007-06-11.
    View PubMed
  67. Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Results of inferior vena caval interruption by Greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol 2007 Aug; 178(2):440-5.
    View PubMed
  68. Thompson RH, Blute ML, Slezak JM, Bergstralh EJ, Leibovich BC. Is GPSM scoring algorithm for patients with prostate cancer valid in contemporary era? J Urol 2007 Aug; 178(2):459-63.
    View PubMed
  69. Thompson RH, Blute ML, Krambeck AE, Lohse CM, Magera JS, Leibovich BC, Kwon ED, Frank I, Cheville JC. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol 2007 Jul; 31(7):1089-93.
    View PubMed
  70. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Frank I, Patterson DE. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol 2007 May; 188(5):1195-200.
    View PubMed
  71. Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE, Sengupta S, Dong H, Cheville JC, Lohse CM, Krco CJ, Webster WS, Leibovich BC, Blute ML, Knutson KL, Kwon ED. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007 Apr 1; 13(7):2075-81.
    View PubMed
  72. Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 2007 Apr 1; 112(7):1471-9.
    View PubMed
  73. Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE, Sengupta S, Dong H, Cheville JC, Lohse CM, Krco CJ, Webster WS, Leibovich BC, Blute ML, Knutson KL, Kwon ED. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007 Apr 1; 13(7):2075-81.
    View PubMed
  74. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Patterson DE, Chow GK, Blute ML. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology 2007 Apr; 243(1):276-83.
    View PubMed
  75. Tollefson MK, Slezak JM, Leibovich BC, Zincke H, Blute ML. Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Mayo Clin Proc 2007 Apr; 82(4):422-7.
    View PubMed
  76. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Patterson DE, Chow GK, Blute ML. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology 2007 Apr; 243(1):276-83.
  77. Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clin Cancer Res 2007 Mar 15; 13(6):1749-56.
    View PubMed
  78. Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res 2007 March; 13(6):1757-61.
  79. Siddiqui SA, Frank I, Leibovich BC, Cheville JC, Lohse CM, Zincke H, Blute ML. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. J Urol 2007 Jan; 177(1):59-62.
    View PubMed
  80. Tollefson MK, Takahashi N, Leibovich BC. Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma. Curr Urol Rep 2007 Jan; 8(1):38-43.
    View PubMed
  81. Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE, Sengupta S, Dong H, Cheville JC, Lohse CM, Krco CJ, Webster WS, Leibovich BC, Blute ML, Knutson KL, Kwon ED. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007; 13(7):2075-81.
  82. Dimashkieh HH, Lohse CM, Blute ML, Kwon ED, Leibovich BC, Cheville JC. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol 2006 Nov; 176(5):1978-82; discussion 1982-3.
    View PubMed
  83. Krambeck AE, Leibovich BC, Lohse CM, Kwon ED, Zincke H, Blute ML. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma. J Urol 2006 Nov; 176(5):1990-5.
    View PubMed
  84. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology 2006 Oct; 68(4):741-6.
    View PubMed
  85. Leibovich BC, Blute ML. Surgical management of renal cell carcinoma. Semin Oncol 2006 Oct; 33(5):552-62.
    View PubMed
  86. Routh JC, Crimmins CR, Leibovich BC, Elliott DS. Impact of Parkinson's disease on continence after radical prostatectomy. Urology 2006 Sep; 68(3):575-7. Epub 2006 Sep 18.
    View PubMed
  87. Inman BA, DiMarco DS, Slezak JM, Sebo TJ, Kwon ED, Leibovich BC, Blute ML, Zincke H. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. Urology 2006 Sep; 68(3):604-8. Epub 2006 Sep 18.
    View PubMed
  88. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Zincke H, Blute ML. Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol 2006 Sep; 176(3):900-3; discussion 903-4.
    View PubMed
  89. Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 2006 Aug 15; 107(4):712-20.
    View PubMed
  90. Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer 2006 Aug 1; 107(3):521-9.
    View PubMed
  91. Sengupta S, Christensen CM, Zincke H, Slezak JM, Leibovich BC, Bergstralh EJ, Myers RP, Blute ML. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. J Urol 2006 Aug; 176(2):559-63.
    View PubMed
  92. Krambeck AE, Thompson RH, Dong HD, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival. Proc Natl Acad Sci U S A 2006 Jul 5; 103(27):10391-6.
    View PubMed
  93. Parker AS, Kosari F, Lohse CM, Thompson RH, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 2006 Jul 1; 107(1):37-45.
    View PubMed
  94. Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival. Cancer 2006 Jul 1; 107(1):46-53.
    View PubMed
  95. Parker AS, Kosari F, Lohse CM, Houston Thompson R, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 2006 Jul 1; 107(1):37-45.
    View PubMed
  96. Sengupta S, Slezak JM, Blute ML, Leibovich BC, Sebo TJ, Myers RP, Cheville JC, Bergstralh EJ, Zincke H. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001. Cancer 2006 Jun 15; 106(12):2630-5.
    View PubMed
  97. Sengupta S, Blute ML, Bagniewski SM, Myers RP, Bergstralh EJ, Leibovich BC, Zincke H. Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival. J Urol 2006 May; 175(5):1684-90; discussion 1690.
    View PubMed
  98. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 2006 Apr 1; 66(7):3381-5.
    View PubMed
  99. Siddiqui SA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Myers RP, Zincke H, Blute ML. Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. J Urol 2006 Mar; 175(3 Pt 1):952-7.
    View PubMed
  100. Tollefson MK, Leibovich BC, Slezak JM, Zincke H, Blute ML. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol 2006 Feb; 175(2):547-51.
    View PubMed
  101. Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer 2006 Jan 15; 106(2):304-12.
    View PubMed
  102. Sengupta S, Cheville JC, Corless CL, Lohse CM, Heinrich MC, Kwon ED, Zincke H, Blute ML, Leibovich BC. Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. J Urol 2006 Jan; 175(1):53-6.
    View PubMed
  103. Webster WS, Leibovich BC. Exisulind in the treatment of prostate cancer. Expert Review of Anticancer Therapy 2005 Dec; 5(6):957-62.
    View PubMed
  104. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR, Blute ML. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: A stratification tool for prospective clinical trials. J Urol 2005 Nov; 174(5):1759-63.
    View PubMed
  105. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Clear cell renal cell carcinoma: Gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 2005 Jul 15; 11(14):5128-39.
    View PubMed
  106. Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED, Frank I, Blute ML, Leibovich BC. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer 2005 Jul 1; 104(1):53-60.
    View PubMed
  107. Sengupta S, Leibovich BC, Blute ML, Zincke H. Surgery for metastatic renal cell cancer. World J Urol 2005 Jul; 23(3):155-60.
    View PubMed
  108. Routh JC, Leibovich BC. Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease. Mayo Clin Proc 2005 Jul; 80(7):899-907.
    View PubMed
  109. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 2005 Jul; 174(1):107-10; discussion 110-1.
    View PubMed
  110. Sengupta S, Zincke H, Leibovich BC, Blute ML. Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series. BJU Int 2005 Jul; 96(1):54-7.
    View PubMed
  111. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 2005 Jun; 173(6):1889-92.
    View PubMed
  112. Chrouser KL, Leibovich BC, Sweat SD, Larson DW, Davis BJ, Tran NV, Zincke H, Blute ML. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol 2005 Jun; 173(6):1953-7.
    View PubMed
  113. Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, Zincke H, Blute ML. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol 2005 Jun; 173(6):1893-6.
    View PubMed
  114. Parker AS, Cheville JC, Lohse CM, Igel T, Leibovich BC, Blute ML. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell, renal cell carcinoma. Urology 2005 Jun; 65(6):1090-5.
    View PubMed
  115. Routh JC, Lischer GH, Leibovich BC. Epididymo-orchitis and testicular abscess due to Nocardia asteroides complex. Urology 2005 Mar; 65(3):591.
    View PubMed
  116. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Kwon ED, Zincke H. pT2 classification for renal cell carcinoma. Can its accuracy be improved? J Urol 2005 Feb; 173(2):380-4.
    View PubMed
  117. Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol 2005 Feb; 173(2):391-4.
    View PubMed
  118. Kwon E, Thompson RH, Gillett M, Cheville J, Lohse C, Dong H, Webster WS, Krejci K, Lobo J, Sengupta S, Leiping C, Zincke H, Blute ML, Strome S, Leibovich BC. Immune cell marker expressed in kidney cancer and predicts aggressiveness. Cancer Biology and Therapy 2004 Dec; 3(12):1199.
    View PubMed
  119. Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED. Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 2004 Nov 15; 173(10):6098-108.
    View PubMed
  120. Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 2004 Aug; 172(2):465-9.
    View PubMed
  121. Miller DV, McClure RF, Crawford BG, Zeldenrust SR, Leibovich BC, Sebo TJ. Histiocytes containing immunoglobulin crystals in the urine of a patient with IgA kappa plasmacytoma of the bladder. Diagn Cytopathol 2004 Jul; 31(1):48-51.
    View PubMed
  122. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004 Jul; 94(1):33-41.
    View PubMed
  123. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, Blute ML. Sarcomatoid renal cell carcinoma - An examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 2004 Apr; 28(4):435-41.
    View PubMed
  124. Mosharafa AA, Foster RS, Leibovich BC, Ulbright TM, Bihrle R, Einhorn LH, Donohue JP. Histology in mixed germ cell tumors. Is there a favorite pairing? J Urol 2004 Apr; 171:1741-3.
  125. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004 Mar; 171(3):1066-70.
    View PubMed
  126. Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP. History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol 2004 Jan 1; 159(1):42-8.
    View PubMed
  127. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Leibovich BC, Zincke H. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol 2003 Dec; 170(6 Pt 1):2225-32.
    View PubMed
  128. Blute ML, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: Importance of tumor histology and risk of metachronous recurrence. J Urol 2003 Sep; 170(3):760-3.
    View PubMed
  129. Mosharafa AA, Foster RS, Leibovich BC, Bihrle R, Johnson C, Donohue JP. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 2003 Jun; 169(6):2126-28.
    View PubMed
  130. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma - A stratification tool for prospective clinical trials. Cancer 2003 Apr 1; 97(7):1663-71.
    View PubMed
  131. Davis BJ, Pisansky TM, Leibovich BC. Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer. Curr Opin Urol 2003 Mar; 13(2):117-22.
    View PubMed
  132. Krejci KG, Leibovich BC. Should there be a size limit for elective nephron-sparing surgery? Current Urology Reports 2003 Feb; 4(1):21-9.
    View PubMed
  133. Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 98:2566-2577.
    View PubMed
  134. Han KR, Pantuck AJ, Bui MH, Shvarts O, Freitas DG, Zisman A, Leibovich BC, Dorey FJ, Gitlitz BJ, Figlin RA, et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology 2003; 61(314-319).
    View PubMed
  135. Han KR, Bui MH, Pantuck AJ, Freitas DG, Leibovich BC, Dorey FJ, Zisman A, Janzen NK, Mukouyama H, Figlin RA, et al. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. (Includes discussion p.903-904). J Urol 2003; 169:899-904.
    View PubMed
  136. Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 2003; 9:802-811.
    View PubMed
  137. Kausik SJ, Blute ML, Sebo TJ, Leibovich BC, Bergstralh EJ, Slezak J, Zincke H. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer 2002 Sep 15; 95(6):1215-9.
    View PubMed
  138. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001 Jul; 166(1):86-91; discussion 91-2.
    View PubMed
  139. Leibovich BC, Blute ML, Bostwick DG, Wilson TM, Pisansky TM, Davis BJ, Ramnani DM, Cheng L, Sebo TJ, Zincke H. Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology 2000 Nov 1; 56(5):726-9.
    View PubMed
  140. Leibovich BC, Cheng L, Weaver AL, Myers RP, Bostwick DG. Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer. J Urol 2000 Jun; 163(6):1756-60.
    View PubMed
  141. Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer 2000 May 15; 88(10):2326-32.
    View PubMed
  142. Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H, Bostwick DG. The cell cycle inhibitors p21(WAF1) and p27(KIP1) are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res 2000 May; 6(5):1896-1899.
    View PubMed
  143. Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Nehra A, Malek RS, Zincke H, Bostwick DG. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 2000 Apr 1; 88(7):1679-86.
    View PubMed
  144. Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 2000 Apr; 163(4):1178-82.
    View PubMed
  145. Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Neumann RM, Nascimento AG, Zincke H, Bostwick DG. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer 2000 Feb 15; 88(4):844-52.
    View PubMed
  146. Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, Scherer BG, Nehra A, Zincke H, Bostwick DG. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 2000 Feb; 113(2):275-9.
    View PubMed
  147. Cheng L, Pisansky TM, Ramnani DM, Leibovich BC, Cheville JC, Slezak J, Bergstralh EJ, Zincke H, Bostwick DG. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol 2000 Feb; 13(2):113-8.
    View PubMed
  148. Cheng L, Pisansky TM, Sebo TJ, Leibovich BC, Ramnani DM, Weaver AL, Scherer BG, Blute ML, Zincke H, Bostwick DG. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. Clin Cancer Res 1999 Oct; 5(10):2820-3.
    View PubMed
  149. Cheng L, Nascimento AG, Neumann RM, Nehra A, Cheville JC, Ramnani DM, Leibovich BC, Bostwick DG. Hemangioma of the urinary bladder. Cancer 1999 Aug 1; 86(3):498-504.
    View PubMed
  150. Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG. Neurofibroma of the urinary bladder. Cancer 1999 Aug 1; 86(3):505-13.
    View PubMed
  151. Cheng L, Neumann RM, Scherer BG, Weaver AL, Leibovich BC, Nehra A, Zincke H, Bostwick DG. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 1999 Jun 15; 85(12):2638-47.
    View PubMed
  152. Cheng L, Leibovich BC, Bergstralh EJ, Scherer BG, Pacelli A, Ramnani DM, Zincke H, Bostwick DG. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer 1999 Jun 1; 85(11):2455-9.
    View PubMed
  153. Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, Bostwick DG. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 1999 Jun 1; 85(11):2469-74.
    View PubMed
  154. Amling CL, Leibovich BC, Lerner SE, Bergstralh EJ, Blute ML, Myers RP, Zincke H. Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate. Semin Urol Oncol 1997 Nov; 15(4):215-21.
    View PubMed
  155. Leibovich BC, Barrett DM. Use of the artificial urinary sphincter in men and women. World J Urol 1997; 15(5):316-9.
    View PubMed
  156. Kallakury BVS, Figge J, Leibovich BC, Hwang J, Rifkin M, Kaufman R, Figge H, Nazeer T, Ross JS. Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2. 8 kb major breakpoint region or with P53 protein accumulation Modern Pathology 1996; 9(1):41-7.


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.